Zanosar
Zanosar
Zanosar (/zænəsɑːr/), also known as streptozocin, is a chemotherapy drug that is primarily used to treat pancreatic cancer. It is a naturally occurring alkylating agent derived from Streptomyces achromogenes, a strain of soil bacteria.
Etymology
The name "Zanosar" is a brand name, while "streptozocin" is derived from the name of the bacteria from which it is isolated, Streptomyces achromogenes. The suffix "-zin" is common in drugs that are alkylating agents.
Usage
Zanosar is used in the treatment of islet cell carcinoma, a rare type of pancreatic cancer. It works by damaging the DNA of cancer cells, which prevents them from dividing and growing. Zanosar is administered intravenously.
Side Effects
Common side effects of Zanosar include nausea, vomiting, and loss of appetite. More serious side effects can include kidney damage and a decrease in blood cells, which can lead to an increased risk of infection, anemia, and bleeding.
Related Terms
External links
- Medical encyclopedia article on Zanosar
- Wikipedia's article - Zanosar
This WikiMD article is a stub. You can help make it a full article.
Languages: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
Urdu,
বাংলা,
తెలుగు,
தமிழ்,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
European
español,
Deutsch,
français,
русский,
português do Brasil,
Italian,
polski